Characterization of a humanized mouse model to study HIV and ARV effects on bone

研究 HIV 和 ARV 对骨骼影响的人源化小鼠模型的表征

基本信息

  • 批准号:
    10324198
  • 负责人:
  • 金额:
    $ 40.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-27 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary / Abstract The development of highly effective antiretroviral (ARV) therapies has significantly increased the lifespan of people living with HIV (PLWH). Yet as HIV has become a chronic disease, it is becoming increasingly clear that PLWH have an increased risk for and an earlier onset of a variety of comorbidities, including osteoporosis. Our long-term goal is to identify the mechanism(s) of HIV and ARV-mediated bone loss. While human studies are highly valuable in defining phenomena and associations, they are complicated by sample accessibility, numerous confounding variables, and limitations in assessing cause and effect. Small animal models can be of value to probe the mechanism(s) implicated in HIV/ARV-induced bone loss. However, a critical barrier in the field is the difficulty in modeling HIV infection and ARV treatment in small animal models. Although several rodent models have been used to study the effects of HIV on bone, each has its own unique limitations. Therefore, in the current proposal we aim to characterize the NSG-HuPBMC mouse model to study the effects of HIV infection and ARV treatment on bone. The model has several key advantages: (1) it is relatively cost effective and less complex than other models, (2) allows for reconstitution and infection of cells of interest, and (3) there is no irradiation or fetal tissue required. The proposal will test the hypothesis that both HIV infection and ARV treatment induce loss of bone mass and reduced bone quality and strength in NSG-HuPBMC mice via two separate but independent aims that will determine the effects of HIV infection (Aim 1) and ARV treatment alone and in combination with HIV infection (Aim 2) on bone. The research proposal is well suited as a high risk/ high reward R21 application because assessing bone loss in this model can potentially establish it as a suitable model for studying HIV skeletal co-morbidities and most importantly define mechanisms that may inform the human condition.
项目总结/摘要 高效抗逆转录病毒(ARV)疗法的发展大大延长了 艾滋病毒感染者(PLWH)。然而,随着艾滋病毒成为一种慢性疾病, PLWH具有多种合并症的增加的风险和更早的发病,包括骨质疏松症。 我们的长期目标是确定HIV和ARV介导的骨丢失的机制。虽然人类研究 在定义现象和关联方面非常有价值,它们因样本可访问性而复杂化, 许多混杂变量,以及评估因果关系的局限性。小动物模型可以是 探讨HIV/ARV诱导骨丢失的机制。然而, 在小动物模型中建立HIV感染和ARV治疗的模型是该领域的难点。尽管几 啮齿动物模型已被用于研究HIV对骨骼的影响,每种模型都有其独特的局限性。 因此,在当前的提议中,我们的目标是表征NSG-HuPBMC小鼠模型以研究 艾滋病感染和抗逆转录病毒治疗的影响。该模型有几个关键的优点:(1)它是相对成本 有效且比其他模型更简单,(2)允许重建和感染感兴趣的细胞,和 (3)不需要辐射或胎儿组织。该提案将检验艾滋病毒感染者和艾滋病患者 和ARV治疗诱导NSG-HuPBMC小鼠中骨量丢失和骨质量和强度降低 通过两个单独但独立的目标,将确定艾滋病毒感染(目标1)和抗逆转录病毒药物的影响, 单独治疗和与HIV感染联合治疗(目的2)。该研究项目非常适合作为 高风险/高回报R21应用,因为在该模型中评估骨丢失可能会建立 作为研究HIV骨骼共病的合适模型,最重要的是定义可能 告知人类的状况。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ryan Dee Ross其他文献

Ryan Dee Ross的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ryan Dee Ross', 18)}}的其他基金

Identifying the long-term metabolic complications of in-utero and lactational antiretroviral exposure
确定子宫内和哺乳期抗逆转录病毒暴露的长期代谢并发症
  • 批准号:
    10762179
  • 财政年份:
    2023
  • 资助金额:
    $ 40.41万
  • 项目类别:
Bone and fat cross-talk in antiretroviral therapy (ART) treated HIV patients
抗逆转录病毒疗法 (ART) 治疗的 HIV 患者的骨和脂肪交叉对话
  • 批准号:
    10548410
  • 财政年份:
    2022
  • 资助金额:
    $ 40.41万
  • 项目类别:
Bone and fat cross-talk in antiretroviral therapy (ART) treated HIV patients
抗逆转录病毒疗法 (ART) 治疗的 HIV 患者的骨和脂肪交叉对话
  • 批准号:
    10856307
  • 财政年份:
    2022
  • 资助金额:
    $ 40.41万
  • 项目类别:
Assessing the function role of sclerostin in periodontal disease in XLH
评估硬化素在 XLH 牙周病中的功能作用
  • 批准号:
    10303753
  • 财政年份:
    2021
  • 资助金额:
    $ 40.41万
  • 项目类别:
Assessing the function role of sclerostin in periodontal disease in XLH
评估硬化素在 XLH 牙周病中的功能作用
  • 批准号:
    10454382
  • 财政年份:
    2021
  • 资助金额:
    $ 40.41万
  • 项目类别:
Sclerostin Regulation of Skeletal Mineralization and Phosphate Metabolism
硬化素对骨骼矿化和磷酸盐代谢的调节
  • 批准号:
    10457434
  • 财政年份:
    2019
  • 资助金额:
    $ 40.41万
  • 项目类别:
Sclerostin Regulation of Skeletal Mineralization and Phosphate Metabolism
硬化素对骨骼矿化和磷酸盐代谢的调节
  • 批准号:
    10240577
  • 财政年份:
    2019
  • 资助金额:
    $ 40.41万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 40.41万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 40.41万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 40.41万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 40.41万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 40.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 40.41万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 40.41万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 40.41万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 40.41万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 40.41万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了